Detalhe da pesquisa
1.
Survival, cost and added therapeutic benefit of drugs granted early access through the French temporary authorization for use program in solid tumors from 2009 to 2019.
Int J Cancer
; 151(8): 1345-1354, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603979